A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Prader-Willi Syndrome

In brief

The purpose of this is study is to evaluate the effects of DCCR (diazoxide choline controlled release tablets) in children and adults with Prader-Willi syndrome.

Key facts

Study ID
NCT03440814
Run by
Soleno Therapeutics, Inc.
People needed
127
Starts
2018-05-09
Expected to finish
2020-05-01
Last updated by the study team
2023-09-21

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.